Clinical Trial

TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation

Study acronym: TRADE
Recruiting
View on ClinicalTrials.gov →
Summary
Tree nut immunotherapy Route Assessment and DEvelopment (TRADE) is a randomized controlled trial that evaluates the efficacy and safety of sublingual immunotherapy and lower, more tolerable, doses of oral immunotherapy than currently in use.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-08-26.
Status change: Not Yet Recruiting → Recruiting 2024-05-30
Trial Details
NCT Number NCT05521711
Lead Sponsor Hamilton Health Sciences Corporation
Collaborators: AAAAI Foundation
Conditions Tree Nut Allergy, Food Allergy
Enrollment 60 participants
Start Date 2023-09-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-06-03